Understanding how cells turn genes on and off is one of biology's most enduring mysteries. Now, a new technology developed by ...

Researchers at Helmholtz Munich and the Technical University of Munich (TUM) have developed Nicheformer, the first ...

Hair follicle stem cells choose one of two paths when faced with DNA damage: graying or (potentially) melanoma.

The available Week 7 survivor pool teams has dwindled even further. Couple that with a number of upsets, including the Thursday night New York Giants win over the Philadelphia Eagles 34-17, and many ...

Aaron Rodgers will get his induction into the Steelers vs. Bengals rivalry on 'Thursday Night Football' to kick off NFL Week 7. Several NFL prop picks will center on Rodgers, Jaylen Warren, DK Metcalf ...

Weather experts are tracking when the next hurricane could impact the United States in October as the 2025 hurricane season does not end until the end of November. As Lorenzo develops as a tropical ...

Developing housing at a price that is attainable to people earning between 80% and 120% of the area median income is more common in suburban locations. In areas like downtown Tempe, acquiring land and ...

The rings of DNA inside mitochondria are inaccessible to these techniques, which means that precise edits to mitochondrial DNA (mtDNA) remain frustratingly out of reach. “Mitochondria missed the ...

A model of American Classic Voyages’ Project America ship recently resurfaced, appearing for sale on eBay earlier this month. The detailed 29-inch ship model shows the proposed original design of the ...

The 2025-26 NBA season tips off in less than two weeks, and the Los Angeles Lakers are once again getting an Opening Night national TV game. They’ll play the Golden State Warriors at 7 p.m. PT on NBC ...

MASPIN (“tumor suppressor shield”): MASPIN is a natural defense protein that blocks tumor invasion, regulates cell migration and angiogenesis, promotes apoptosis, and enhances treatment sensitivity.

MIAMI, FLORIDA / ACCESS Newswire / October 7, 2025 / Telomir Pharmaceuticals, Inc. (NASDAQ:TELO) (“Telomir” or the “Company”), a preclinical-stage biotechnology company developing therapies that ...